Results 171 to 180 of about 8,086 (233)

Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy. [PDF]

Int J Mol Sci
Florea AM, Luca DG, Davidescu EI, Popescu BO.   +3 more
europepmc   +1 more source

Case Report: KLHL11 encephalitis in a female patient with dual primary malignancies of breast and lung cancer: response to FcRn inhibitor therapy. [PDF]

Front Immunol
Li Y, Xing H, Cao Z, Cui P, Zhao L.
europepmc   +1 more source

Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8 ⁻ CD11b ⁺ dendritic cells

, 2011
Kristi Baker, Shuo‐Wang Qiao, Timothy Kuo, Victoria G. Aveson, Barbara Platzer, Jan Terje Andersen, Inger Sandlie, Zhangguo Chen, Colin de Haar, Wayne I. Lencer, Edda Fiebiger, Richard S. Blumberg   +11 more
openalex   +2 more sources

FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. [PDF]

Antibodies (Basel)
Sandhu M, Murakhovskaya I.
europepmc   +1 more source

Cross-Species Extrapolationof Neonatal Fc Receptor(FcRn) Binding Affinity to Predict Monoclonal Antibody Pharmacokineticsin Humans Using Physiologically Based Pharmacokinetic Modeling (PBPK):Are We There Yet?

Salih Benamara (21986200), Carla Troisi (21986203), Florence Gattacceca (1906090), Erik Sjögren (1593622), Laurent Nguyen (63738), Donato Teutonico (4990037)   +5 more
openalex   +1 more source

Nipocalimab: a significant milestone in the treatment of myasthenia gravis approved by the FDA. [PDF]

Ann Med Surg (Lond)
Irfan S, Sana M, Haque MA.
europepmc   +1 more source

Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance. [PDF]

Front Immunol
Remaily BC, Young G, Lathrop H, Thomas J, Kim K, Vu TT, Adeluola A, Stanton C, Mulcahy G, Xie Z, Granchie L, Guo Y, Hai M, Wedig J, Schmidt M, Manna M, Mo X, Lowe J, Rafael-Fortney JA, Folefac E, Gregorevic P, Owen DH, Kulp SK, Ganesan LP, Coss CC, Mace TA, Phelps MA.   +26 more
europepmc   +1 more source

Quantitative Prediction of Human Pharmacokinetics for Fc-Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection. [PDF]

Clin Transl Sci
Haraya K, Kuramochi T.
europepmc   +1 more source

Potential drug interaction between calcitonin gene-related peptide antagonists and neonatal Fc receptor inhibitors. [PDF]

Headache
Harlan A, Weber K.
europepmc   +1 more source

FcRn Blockers: Neonatal Fc Receptor at the Interface of Balancing Immune Modulation and Persevering Protective Humoral Immunity

D. Ghosh, Abhishek Saxena, Alok Kumar, Jia Wang, Weihuan Wen   +4 more
openalex   +1 more source